These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9298468)

  • 1. HIV RNA quantitation: marker of HIV infection.
    Melroe NH; Stawarz KE; Simpson J; Henry WK
    J Assoc Nurses AIDS Care; 1997; 8(5):31-8. PubMed ID: 9298468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma viral load testing in the management of HIV infection.
    Mylonakis E; Paliou M; Rich JD
    Am Fam Physician; 2001 Feb; 63(3):483-90, 495-6. PubMed ID: 11272298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved HIV-1 RNA quantitation by COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0 using a novel dual-target approach.
    Sizmann D; Glaubitz J; Simon CO; Goedel S; Buergisser P; Drogan D; Hesse M; Kröh M; Simmler P; Dewald M; Gilsdorf M; Fuerst M; Ineichen R; Kirn A; Pasche P; Wang Z; Weisshaar S; Young K; Haberhausen G; Babiel R
    J Clin Virol; 2010 Sep; 49(1):41-6. PubMed ID: 20637687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Undetectable HIV-1 RNA load with the Cobas TaqMan v1.0 in a patient diagnosed at the time of primary HIV-1 infection.
    Ghosn J; Galimand J; Meyer L; Descamps D; Vabret A; Deveau C; Yéni P; Goujard C; Rouzioux C; Chaix ML;
    J Med Virol; 2010 Nov; 82(11):1816-8. PubMed ID: 20872706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of real-time PCR for HIV-1 RNA and DNA quantitation in patients infected with HIV-1 BF intersubtype recombinant variants.
    Schvachsa N; Turk G; Burgard M; Dilernia D; Carobene M; Pippo M; Gómez-Carrillo M; Rouzioux C; Salomon H
    J Virol Methods; 2007 Mar; 140(1-2):222-7. PubMed ID: 17166599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype C-infected patients from South Africa.
    Stevens G; Rekhviashvili N; Scott LE; Gonin R; Stevens W
    J Clin Microbiol; 2005 Feb; 43(2):857-61. PubMed ID: 15695692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virologic testing in the management of perinatal HIV exposure.
    Cervia J; Kaplan B; Schuval S; Weiss S
    AIDS Read; 2003 Jan; 13(1):39-47. PubMed ID: 12569894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of HIV RNA in patients infected by subtype C by assays optimized for subtype B results in an underestimation of the viral load.
    Gottesman BS; Grosman Z; Lorber M; Levi I; Shitrit P; Mileguir F; Gottesman G; Chowers MY
    J Med Virol; 2004 Jun; 73(2):167-71. PubMed ID: 15122788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HIV viral load and preventive HIV load in primary health care].
    Vall Mayans M
    Aten Primaria; 1997 Nov; 20(8):399-400. PubMed ID: 9462932
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive polymerase chain reaction assay for quantitation of HIV-1 DNA and RNA.
    Stieger M; Démollière C; Ahlborn-Laake L; Mous J
    J Virol Methods; 1991; 34(2):149-60. PubMed ID: 1804850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meaning of DNA detection during the follow-up of HIV-1 infected patients: a brief review.
    Re MC; Vitone F; Bon I; Schiavone P; Gibellini D
    New Microbiol; 2006 Apr; 29(2):81-8. PubMed ID: 16841548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution in the sensitivity of quantitative HIV-1 viral load tests.
    Cobb BR; Vaks JE; Do T; Vilchez RA
    J Clin Virol; 2011 Dec; 52 Suppl 1():S77-82. PubMed ID: 22036041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons learned from HIV pathogenesis and therapy: implications for better management of cytomegalovirus disease.
    Hardy WD
    AIDS; 1996 Nov; 10 Suppl 1():S31-5. PubMed ID: 8970674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 viral dynamics and viral load measurement: implications for therapy.
    Riddler SA; Mellors JW
    AIDS Clin Rev; 1997-1998; ():47-65. PubMed ID: 9305443
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the COBAS TAQMAN HIV-1 HPS with VERSANT HIV-1 RNA 3.0 assay (bDNA) for plasma RNA quantitation in different HIV-1 subtypes.
    Gomes P; Palma AC; Cabanas J; Abecasis A; Carvalho AP; Ziermann R; Diogo I; Gonçalves F; Lobo CS; Camacho R
    J Virol Methods; 2006 Aug; 135(2):223-8. PubMed ID: 16675034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals.
    Taylor N; Schmid I; Egle A; Greil R; Patsch W; Oberkofler H
    Antivir Ther; 2009; 14(8):1189-93. PubMed ID: 20032549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 viral load: comparative evaluation of three commercially available assays in Argentina.
    Hodara V; Monticelli A; Pampuro S; Salomón H; Jauregui Rueda H; Libonatti O
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(2):107-13. PubMed ID: 9695883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 load quantitation: a 17-year perspective.
    Holodniy M
    J Infect Dis; 2006 Sep; 194 Suppl 1():S38-44. PubMed ID: 16921471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.